Lagos, Nigeria – Fidson Healthcare Plc has reported a profit before tax of N14.96 billion (approximately $9.56 million) for the 2025 financial year, representing a 94 percent increase from N7.7 billion recorded in 2024, according to the company’s audited financial statement.
Okay News reports that the pharmaceutical firm also proposed a total dividend of N3.6 billion for the year, translating to N1.50 per share, a more than 50 percent increase from the N2.29 billion (N1.00 per share) declared in 2024. Revenue rose 41 percent to N119.06 billion, driven by strong demand across its pharmaceutical portfolio.
Gross profit increased 40 percent to N49.23 billion, while operating profit climbed 67 percent to N21.95 billion. Profit after tax surged 125 percent to N9.88 billion, and earnings per share rose to 412 kobo from 192 kobo in the prior year.
Despite the strong earnings growth, Fidson faced notable headwinds. Finance costs increased 30 percent to N7.13 billion, and the company recorded a net exchange loss of N6.01 billion, highlighting continued exposure to foreign exchange volatility.
Total assets increased 9 percent to N80.29 billion, while total liabilities declined 2 percent to N50.09 billion, indicating improved debt management. Total equity attributable to shareholders rose 35 percent to N30.2 billion, with retained earnings up 47 percent to N23.98 billion.
The share price began the year at N50.10 and has since gained 99.6 percent, ranking it 17th on the Nigerian Exchange in year-to-date performance. With 2.4 billion shares outstanding valued at N240 billion, Fidson Healthcare is currently the 44th most valuable stock on the exchange.
 for the 2025 financial year, representing a 94 percent increase from N7.7 billion recorded in 2024, according to the company's audited financial statement.){kind=link}